Anti-amyloid beta single-chain Fv ameliorates behavioral impairment in Alzheimer's disease mice via adeno-associated virus delivery

Neural Regeneration Research

Volumn 6, Issue 2, 2011, Pages 96-100

  Cai, Jiong ^a   Zhong, Yanwei ^b   Li, Fang ^a   Wang, Shizhen ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

Adeno associated virus; Alzheimer's disease; Amyloid peptide; Neural regeneration; Neurodegenerative diseases; Single chain antibody

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; PLATELET DERIVED GROWTH FACTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ADENO ASSOCIATED VIRUS; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BLOOD BRAIN BARRIER; COGNITION; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

EID: 79951707596     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.02.003     Document Type: Article

References (34)

1. Salminen A, Ojala J, Suuronen T, et al. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med. 2008;12(6A):2255-2262.
2. Weksler ME, Relkin N, Turkenich R, et al. Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals. Exp Gerontol. 2002; 37(7):943-948.
3. Morgan D, Diamond DM, Gottschall PE, et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 2000;408(6815):982-985.
4. Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400(6740):173-177.
5. Janus C, Pearson J, McLaurin J, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000;408(6815):979-982.
6. Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6(8):916-919.
7. Racke MM, Boone LI, Hepburn DL, et al. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. J Neurosci. 2005;25(3):629-636.
8. Cai J, Wang S, Zhong Y, et al. Screening and characterization of human single-chain Fv antibody against beta-amyloid peptide 40. Neuroreport. 2003;14(2):265-268.
9. Levites Y, Jansen K, Smithson LA, et al. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J Neurosci. 2006;26(46):11923-11928.
10. Lo AS, Zhu Q, Marasco WA. Intracellular antibodies (intrabodies) and their therapeutic potential. Handb Exp Pharmacol. 2008(181): 343-373.
11. Kasturirangan S, Sierks M. Targeted hydrolysis of beta-amyloid with engineered antibody fragment. Curr Alzheimer Res. 2010; 7(3):214-222.
12. Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell. 2010;142(6):857-867.
13. Salek RM, Xia J, Innes A, et al. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int. 2010;56(8):937-947.
14. Manthey D, Gamerdinger M, Behl C. The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities. Br J Pharmacol. 2010;159(6):1264-1273.
15. Sheng B, Song B, Zheng Z, et al. Abnormal cleavage of APP impairs its functions in cell adhesion and migration. Neurosci Lett. 2009;450(3):327-331.
16. Cai J, Li F, Liu F, et al. Biological activity of human single-chain antibody against amyloid beta peptide involved in Alzheimer's disease. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007;29(5): 647-650.
17. Lu S, Yu Y, Gao Y, et al. Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats. Hepatobiliary Pancreat Dis Int. 2008;7(3): 258-263.
18. Li H, Qiu W, Wang F, et al. Construction and expression of recombinant adeno-associated virus expressing brain-derived neurotrophic factor. Sheng Wu Gong Cheng Xue Bao. 2008;24(2): 328-332.
19. Clément N, Knop DR, Byrne BJ. Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies. Hum Gene Ther. 2009;20(8): 796-806.
20. Thomas DL, Wang L, Niamke J, et al. Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells. Hum Gene Ther. 2009;20(8):861-870.
21. Dong X, Tian W, Yuan Z, et al. A novel packaging system of recombinant AAV5/5 vector. Sheng Wu Gong Cheng Xue Bao. 2010;26(5):679-686.
22. Li W, Zhang L, Johnson JS, et al. Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium. Mol Ther. 2009;17(12): 2067-2077.
23. Zhou X, Zeng X, Fan Z, et al. Adeno-associated virus of a single-polarity DNA genome is capable of transduction in vivo. Mol Ther. 2008;16(3):494-499.
24. Chung CY, Koprich JB, Siddiqi H, et al. Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy. J Neurosci. 2009;29(11): 3365-3373.
25. Wang XH, Li L, Hölscher C, et al. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats. Neuroscience. 2010;170(4):1239-1248.
26. Rich NJ, Van Landingham JW, Figueiroa S, et al. Chronic caloric restriction reduces tissue damage and improves spatial memory in a rat model of traumatic brain injury. J Neurosci Res. 2010; 88(13):2933-2939.
27. Linkous DH, Adlard PA, Wanschura PB, et al. The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice. J Alzheimers Dis. 2009;18(3):565-579.
28. Kimani ST, Nyongesa AW. Effects of single daily khat (Catha edulis) extract on spatial learning and memory in CBA mice. Behav Brain Res. 2008;195(1):192-197.
29. Chen J, Long Y, Han M, et al. Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice. Pharmacol Biochem Behav. 2008;90(3):441-446.
30. Rex TS, Wong Y, Kodali K, et al. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res. 2009;89(5): 735-740.
31. Abida WM, Gu W. p53-dependent and p53-independent activation of autophagy by ARF. Cancer Res. 2008;68(2):352-357.
32. 2+ ATPase (SERCA1) in German shepherd dogs with dilated cardiomyopathy myocardium. J Vet Cardiol. 2010;12(1):17-23.
33. Kurabayashi R, Takubo K, Aida J, et al. Luminal and cancer cells in the breast show more rapid telomere shortening than myoepithelial cells and fibroblasts. Hum Pathol. 2008;39(11): 1647-1655.
34. Wang YJ, Pollard A, Zhong JH, et al. Intramuscular delivery of a single chain antibody gene reduces brain Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Aging. 2009; 30(3):364-376.